Results 211 to 220 of about 204,688 (384)

Protective effects of neutrophil serine protease inhibition against ischemia–reperfusion injury in lung or heart transplantation

open access: yesThe FEBS Journal, EarlyView.
A major complication of organ transplantation is primary graft dysfunction, which represents the leading cause of early post‐transplantation morbidity and mortality. Pre‐operative depletion of neutrophil serine proteases in circulating neutrophils by pretreatment with a cathepsin C inhibitor in recipients could prevent early post‐operative ...
Sevil Korkmaz‐Icöz   +6 more
wiley   +1 more source

Adult-onset Still's disease during pregnancy: two case reports and a comprehensive literature review. [PDF]

open access: yesFront Med (Lausanne)
Xu W   +8 more
europepmc   +1 more source

Measurement of Tralokinumab Concentrations in Serum and Tear Fluid of Atopic Dermatitis Patients and the Relationship With Treatment Response and Ocular Surface Disease

open access: yes
Clinical &Experimental Allergy, EarlyView.
Coco Dekkers   +11 more
wiley   +1 more source

Tear Cytokine Changes up to One Year After Allogeneic Hematopoietic Stem Cell Transplant: Effect of Daily Topical Cyclosporine-A 0.1% Emulsion. [PDF]

open access: yesInt J Mol Sci
Tong L   +11 more
europepmc   +1 more source

Tacrolimus in solid organ transplantation [PDF]

open access: yes, 1996
Fung, JJ, Starzl, TE, Todo, S
core  

Effectiveness of Bimekizumab in Psoriatic Arthritis: A Multicenter Real‐Life Study With Clinical and Ultrasound Evaluation in the Lazio Region, Italy

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Bimekizumab, a monoclonal antibody targeting interleukin (IL)‐17A and IL‐17F, has shown efficacy in psoriatic arthritis (PsA) clinical trials, but real‐world data on its effectiveness are limited. This study aimed to evaluate its real‐world effectiveness in PsA patients treated in dermatologic settings.
Giacomo Caldarola   +12 more
wiley   +1 more source

Managing IEC-associated enterocolitis following CAR-T therapy in multiple myeloma. [PDF]

open access: yesBlood Cancer J
Banerjee R   +5 more
europepmc   +1 more source

Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study

open access: yesInternational Journal of Dermatology, EarlyView.
ABSTRACT Background Conjunctivitis is among the most frequent adverse events (AEs) emerged in clinical trials for all biologic drugs approved for atopic dermatitis (AD). However, real‐world comparative data on the incidence, risk factors, and management of conjunctivitis remain limited.
Luca Potestio   +50 more
wiley   +1 more source

Home - About - Disclaimer - Privacy